Figure 3
From: Lymphatic vessel density and function in experimental bladder cancer
A-D. Increased lymphatic vessel density during bladder cancer progression. LYVE-1 IHC quantification of lymphatic vessel density (LVD) in bladders isolated from control and SV40-lacZ mice. A = Representative photomicrographs of LYVE-1 IHC. B = Neurolucida tracing of lymphatics. C = Lymphatic vessel density during cancer progression in whole mount preparations of LYVE-1 stained bladders isolated from SV40-lacZ mice compared to control (FVB-κB-lacZ = pink). D = Lymphatic vessel density during cancer progression in cross-section preparations of LYVE-1 stained bladders isolated from SV40-lacZmice compared to control (FVB-κB-lacZ = pink). Asterisks indicate a statistical significant difference (p < 0.05) between FVB-C57BL/6 and SV40-lacZ mice.